Testing a hepatitis C screening tool in the ER
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study tests a new tool that helps doctors in the emergency department quickly check if a patient needs testing for hepatitis C. The goal is to find more cases early and connect people to care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 79 years old.
- You must be medically stable at the time of screening.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what patients think about and are willing to use a quick “point-of-care” blood test for hepatitis C virus (HCV) after a positive antibody screen. It may help the ER find people with possible active infection faster and improve how testing is offered.
This study is testing a tool to find people who may be at risk for or already have HIV or hepatitis C. It aims to connect them with care and support.
This trial studies point-of-care (on-site) testing to find hepatitis C in adults who are at higher risk. If hepatitis C is found, earlier detection can help you get connected to care sooner.
This trial tests a convenient way to screen people who use drugs or are in vulnerable situations for hepatitis B, C, and HIV using rapid tests and a liver scanner. The goal is to see if offering these tests in community settings (like shelters or mobile clinics) is acceptable and works well.
This study tests whether people who come to the emergency department can get tested for hepatitis C and start treatment right away, all in one visit. It aims to make treatment easier and faster for those who test positive.
This trial tests whether a patient-friendly electronic app given in the emergency department can increase what you know about hepatitis C and help you move to the next steps of care. It may be most helpful for people who are hepatitis C–positive but don’t yet have clear information about their status.
Hear when a new Hepatitis C Virus (HCV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.